Application 210824
- Type
- ANDA
- Sponsor
- QILU PHARM CO LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BORTEZOMIB | BORTEZOMIB | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 3.5MG/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50742-484 | Bortezomib | Bortezomib | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 67184-0530 | Bortezomib | Bortezomib | Qilu Pharmaceutical Co., Ltd. | ANDA | Current |
| 68001-540 | Bortezomib | Bortezomib | BluePoint Laboratories | ANDA | Current |
| 70860-225 | Bortezomib | bortezomib | Athenex Pharmaceutical Division, LLC. | ANDA | Current |